Apellis Announces New Data Demonstrating Correlation between Complement Activation and COVID-19 Severity

NEXT STORY
OncXerna Therapeutics to Participate at the Jefferies Virtual London Healthcare Conference
PREV STORY
Reata Pharmaceuticals, Inc. Announces Presentation of KIDNEYCODE Program at the American Society of Nephrology Kidney Week 2020 Reimagined
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Anthera Announces That Data From the Phase 2 BRIGHT-SC Study Has Been Accepted as a Late Breaking Abstract at the ASN Kidney Week 2016 Annual Meeting

HAYWARD, Calif., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) today announced ...

author_avatar
NASDAQ Market News

Coherus Announces Positive Results of UDENYCA® On-Body Injector Clinical Trial

author_avatar
NASDAQ Market News

Immatics Announces Third Quarter 2020 Financial Results and Business Update

author_avatar
NASDAQ Market News